Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Townsend

Showing results (481-490 of 583) with videos related to

Pageof 59
Sort By:
Immunity|August 2, 2002
IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13Padraic G Fallon, Helen E Jolin, Philippa Smith, et al.
Investigational New Drugs|May 11, 2002
Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group studySarah A Taylor, Cathryn Rankin, Jeannette J Townsend, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genesRichard G Jenner, Michael J Townsend, Ian Jackson, et al.
The European Respiratory Journal|November 1, 1990
Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosisC Prior, R A Barbee, P M Evans, et al.
Developmental Medicine and Child Neurology|August 24, 1999
Early brain proton magnetic resonance spectroscopy and neonatal neurology related to neurodevelopmental outcome at 1 year in term infants after presumed hypoxic-ischaemic brain injuryP N Amess, J Penrice, M Wylezinska, et al.
The Biochemical Journal|April 18, 1998
Identification of a novel murine glutathione S-transferase class mu geneW C De Bruin, R H Te Morsche, M J Wagenmans, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Pancreatitis and Hyperlipasemia in the Setting of Immune Checkpoint Inhibitor TherapyMatthew J Townsend, Mofei Liu, Anita Giobbie-Hurder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancerL C Alpert, R L Schecter, D A Berry, et al.
Annals of the Rheumatic Diseases|June 4, 2015
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)Kenneth C Kalunian, Joan T Merrill, Romeo Maciuca, et al.
Health Technology Assessment (Winchester, England)|June 30, 2005
An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and WalesP Roderick, T Nicholson, A Armitage, et al.
Pageof 59

Showing results (481-490 of 583) with videos related to

Sort By:
Pageof 59
Immunity|August 2, 2002
IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13Padraic G Fallon, Helen E Jolin, Philippa Smith, et al.
Investigational New Drugs|May 11, 2002
Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group studySarah A Taylor, Cathryn Rankin, Jeannette J Townsend, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genesRichard G Jenner, Michael J Townsend, Ian Jackson, et al.
The European Respiratory Journal|November 1, 1990
Lavage versus serum measurements of lysozyme, angiotensin converting enzyme and other inflammatory markers in pulmonary sarcoidosisC Prior, R A Barbee, P M Evans, et al.
Developmental Medicine and Child Neurology|August 24, 1999
Early brain proton magnetic resonance spectroscopy and neonatal neurology related to neurodevelopmental outcome at 1 year in term infants after presumed hypoxic-ischaemic brain injuryP N Amess, J Penrice, M Wylezinska, et al.
The Biochemical Journal|April 18, 1998
Identification of a novel murine glutathione S-transferase class mu geneW C De Bruin, R H Te Morsche, M J Wagenmans, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Pancreatitis and Hyperlipasemia in the Setting of Immune Checkpoint Inhibitor TherapyMatthew J Townsend, Mofei Liu, Anita Giobbie-Hurder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancerL C Alpert, R L Schecter, D A Berry, et al.
Annals of the Rheumatic Diseases|June 4, 2015
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)Kenneth C Kalunian, Joan T Merrill, Romeo Maciuca, et al.
Health Technology Assessment (Winchester, England)|June 30, 2005
An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and WalesP Roderick, T Nicholson, A Armitage, et al.
Pageof 59